SAPS 3、SOFA与APACHE II评分对外科ICU患者死亡率预测的预后准确性评估:一项外部验证研究与决策分析
本研究为外部验证研究,评估SOFA、SAPS 3与APACHE II在急诊或择期手术后入住ICU的外科患者中对ICU内死亡与院内死亡的预后准确性,并通过ROC曲线下面积评估区分度、校准度评估模型拟合,再以净获益分析评价临床决策价值。结果显示三种评分区分度均为中等(ICU内死亡AUROC:APACHE II 0.808、SAPS 3 0.821、SOFA 0.797;院内死亡AUROC:APACHE II 0.772、SAPS 3 0.790、SOFA 0.742),但多个风险阈值处观察值与预期值相关性弱,校准差。净获益分析显示,当计算死亡概率在10%–40%之间时,各评分对临床决策有聚合价值。作者认为这些评分是术后外科患者死亡预测的尚可工具,可能作为辅助数据支持医生和家属关于治疗强度与姑息治疗的决策。
要点
- 在术后外科ICU患者中,三种评分对ICU内死亡的区分度(AUROC)为APACHE II 0.808、SAPS 3 0.821、SOFA 0.797,对院内死亡为APACHE II 0.772、SAPS 3 0.790、SOFA 0.742,均属中等。
- 校准评估显示,各模型在多个风险阈值处观察值与预期值相关性弱,校准差。
- 净获益分析显示,当计算死亡概率在10%–40%之间时,各评分对临床决策有聚合价值。
- 作者认为这些评分是术后外科患者ICU内及院内死亡预测的尚可工具,可能作为辅助数据支持医生和家属关于治疗强度与姑息治疗的决策。
适用人群与场景
- 急诊或择期手术后入住ICU的外科患者。
研究设计与关键结果
- 研究类型为外部验证研究,评估SOFA、SAPS 3与APACHE II对术后外科ICU患者ICU内死亡与院内死亡的预后准确性,并分析其决策价值。
- 区分度:ICU内死亡AUROC为APACHE II 0.808、SAPS 3 0.821、SOFA 0.797;院内死亡AUROC为APACHE II 0.772、SAPS 3 0.790、SOFA 0.742。
- 校准评估显示,各模型在多个风险阈值处观察值与预期值相关性弱,校准差。
- 净获益分析显示,当计算死亡概率在10%–40%之间时,各评分对临床决策有聚合价值。
证据类型、等级与局限
- 证据类型:外部验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,SOFA、SAPS 3与APACHE II是术后外科ICU患者ICU内及院内死亡预测的尚可工具。
- 作者认为,这些评分可能作为辅助数据,支持医生和家属关于治疗强度与姑息治疗的决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The early postoperative period is critical for surgical patients. SOFA, SAPS 3 and APACHE II are prognostic scores widely used to predict mortality in ICU patients. This study aimed to evaluate these index tests for their prognostic accuracy for intra-ICU and in-hospital mortalities as target conditions in patients admitted to ICU after urgent or elective surgeries and to test whether they aid in decision-making. The process comprised the assessment of discrimination through analysis of the areas under the receiver operating characteristic curves and calibration of the prognostic models for the target conditions. After, the clinical relevance of applying them was evaluated through the measurement of the net benefit of their use in the clinical decision.
RESULTS: Index tests were found to discriminate regular for both target conditions with a poor calibration (C statistics-intra-ICU mortality AUROCs: APACHE II 0.808, SAPS 3 0.821 and SOFA 0.797/in-hospital mortality AUROCs: APACHE II 0.772, SAPS 3 0.790 and SOFA 0.742). Calibration assessment revealed a weak correlation between the observed and expected number of cases in several thresholds of risk, calculated by each model, for both tested outcomes. The net benefit analysis showed that all score's aggregate value in the clinical decision when the calculated probabilities of death ranged between 10 and 40%.
CONCLUSIONS: In this study, we observed that the tested ICU prognostic scores are fair tools for intra-ICU and in-hospital mortality prediction in a cohort of postoperative surgical patients. Also, they may have some potential to be used as ancillary data to support decision-making by physicians and families regarding the level of therapeutic investment and palliative care.
参考来源
- Falcão ALE, Barros AGA, Bezerra AAM, et al. The prognostic accuracy evaluation of SAPS 3, SOFA and APACHE II scores for mortality prediction in the surgical ICU: an external validation study and decision-making analysis. Ann Intensive Care. 2019. PMID: 30701392. doi:10.1186/s13613-019-0488-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。